亚欧洲日韩国产精品,久久99加热有精品,欧洲精品久久

Amgen Full Year 2025 Financial Report Amgen Amgen's 2025 revenue rose 10%, reaching $36.75B, driven by strong product sales and innovation. The company projects continued growth in 2026, with a focus on R&D, cost control, and shareholder returns.
ASCO 2025: Opening a New Era of "Cancer Eradication" ASCO Discover the latest breakthroughs from ASCO 2025, including innovative cancer treatments, immunotherapy advances, bispecific antibodies, and promising breast cancer therapies shaping the future of oncology.
Top 16 Best-Selling New Drugs Worldwide in 2024 Market Trend Discover the top 16 best-selling new drugs of 2024, featuring innovative FIC and BIC molecules, breakthrough therapies across various fields, and products that stood out due to unique development strategies.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024 Autoimmune The autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Biotech Giants Performance Comparison 2024 Market Trend Compare the 2024 financial performance of top biotech giants, including Vertex, Amgen, Gilead, Regeneron, and Biogen. Explore revenue, net profit, R&D investment, and market trends shaping the biotech industry.
Amgen 2024 Q4 Financial Report Financial statements Amgen reports strong 2024 earnings but faces a setback as the FDA halts its obesity drug AMG 513. Despite this, progress continues with other promising weight loss candidates like MariTide.
Top 10 Immunology Drugs to Watch in 2024 AbbVie Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
Best-in-Class GLP-1 Drugs: Who Will Lead the Market? Viking or Amgen? Viking Explore the competition in the GLP-1 drug market, comparing Viking's oral VK2735 and Amgen's long-acting MariTide to Novo Nordisk and Eli Lilly's market leaders in weight loss and diabetes treatment.

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水